![]() |
|
|
Vol. 301, Issue 3, 790-796, June 2002
Department of Pharmacology and Toxicology, Medical College of
Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
Scientific progress in the biological sciences increasingly relies on
an integration of behavioral, pharmacological, cellular, and molecular
approaches, particularly in translating basic research observations
into therapeutic potential. The strength of in vivo model systems lies
in the direct assessment of physiological function. However, they only
allow indirect evidence for mechanism of action. Frequently, in vitro
models provide just the opposite. A combination of both in vitro and in
vivo approaches are often essential for establishing the underlying
mechanisms of a specific pharmacological effect. In recent times, an
endogenous cannabinoid system has been characterized due to the
combined efforts of chemists, pharmacologists, molecular and cellular
biologists, and biochemists. This endogenous cannabinoid system is
providing a basis for systematically addressing the pharmacological
controversies surrounding marijuana. The description of this endogenous
cannabinoid system and the strategies for establishing the
physiological function of this system are the subjects of this article.
This article has been cited by other articles:
![]() |
J. Cami and M. Farre Drug Addiction N. Engl. J. Med., September 4, 2003; 349(10): 975 - 986. [Full Text] [PDF] |
||||